Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3802 | Sulfonatoporphyrin(TPPS) plus Sunlight exposure. Wiki | 1.00 |
| drug3651 | SnPP Protoporphyrin plus Sunlight exposure Wiki | 0.58 |
| drug1396 | Enoxaparin Wiki | 0.27 |
Navigate: Correlations HPO
There is one clinical trial.
To evaluate the safety and efficacy of the use of inhalational heparin in patients with pulmonary compromise / pneumonia / SARS associated with COVID-19, laboratory with marked inflammation parameters, and prothrombotic state secondary to it (Fibrinogen, Ferritin and / or elevated D-Dimer) , from admission to hospitalization. The combination of inhalation heparin combined with prophylactic doses of LMWH could reduce the progression to severe forms of the disease, and consequently the need for intensive care units and mechanical ventilation.
Description: Blood Gas criteria :PaO2 / FiO2 <200 (or the inability to maintain an SpO2 of at least 92% with a reservoir mask). Acute ventilatory failure (pH less than 7.35 with PaCO2 greater than 45 mmHg)
Measure: Percentage of patients requirement mechanical ventilation Time: 15 daysDescription: Mean every 48 hours PaO2 to FiO2 ratio
Measure: Percentage of patients with PaO2 to Fi02 ratio > 300 Time: 7 daysDescription: To compare the lengths of hospital-stay
Measure: Lengths of hospital-stay Time: Days 60Description: All cause mortality
Measure: Mortality rate Time: 30 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports